Table 3.
Vertigo frequency before and after treatment with cinnarizine
| Variable, mean ± SD | Total vertigo population (n = 40) | Subgroups | ||
|---|---|---|---|---|
| Vestibular migraine (n = 24) | Migraine with brainstem aura (n = 16) | p-value1 | ||
| Monthly frequency of vertigo attacks | ||||
| At baseline | 3.68 ± 1.05 | 3.79 ± 1.14 | 3.50 ± 0.89 | 0.372 |
| 12-week treatment period | ||||
| 1st 4-week | 1.30 ± 1.07* | 1.54 ± 1.10* | 0.94 ± 0.93* | 0.079 |
| 2nd 4-week | 0.60 ± 0.67* | 0.79 ± 0.72* | 0.31 ± 0.48* | 0.016 |
| 3rd 4-week | 0.35 ± 0.65* | 0.42 ± 0.65* | 0.25 ± 0.58* | 0.402 |
*p < 0.05 compared with baseline.
1p-value for comparison between vestibular migraine and migraine with brainstem aura.